Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Douglas_Bryant
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:formedByMergerOf |
gptkb:Quidel_Corporation
gptkb:Ortho_Clinical_Diagnostics |
| gptkbp:founded |
2022
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
QuidelOrtho Corporation
|
| gptkbp:industry |
medical diagnostics
|
| gptkbp:notableEvent |
merger completed in May 2022
|
| gptkbp:numberOfEmployees |
approximately 6,000
|
| gptkbp:parentCompany |
none
|
| gptkbp:predecessor |
gptkb:Quidel_Corporation
gptkb:Ortho_Clinical_Diagnostics |
| gptkbp:product |
gptkb:COVID-19_tests
molecular diagnostic systems diagnostic tests immunoassay systems |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:QDEL
|
| gptkbp:website |
https://www.quidelortho.com/
|
| gptkbp:bfsParent |
gptkb:ORTHO_Clinical_Diagnostics_VITROS_Systems
|
| gptkbp:bfsLayer |
8
|